Clinicians should be aware of the potential risk of recurrence when using IL-17 blockers in patients who have previously experienced a LP/LP-like eruption due to anti- TNF-a antagonists.
Lichen planus triggered by CT-P13 and recurrence during secukinumab treatment / Maglie, R.; Di Cesare, A.; Lazzeri, L.; Pescitelli, L.; Ricceri, F.; Vannucchi, M.; Massi, D.; Prignano, F.. - In: BRITISH JOURNAL OF DERMATOLOGY. - ISSN 0007-0963. - ELETTRONICO. - 178:(2018), pp. 303-304. [10.1111/bjd.16003]
Lichen planus triggered by CT-P13 and recurrence during secukinumab treatment
DI CESARE, ALESSIA;Pescitelli, L.;Massi, D.;Prignano, F.;Maglie, R.
2018
Abstract
Clinicians should be aware of the potential risk of recurrence when using IL-17 blockers in patients who have previously experienced a LP/LP-like eruption due to anti- TNF-a antagonists.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Maglie_et_al-2018-British_Journal_of_Dermatology (1).pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
287.98 kB
Formato
Adobe PDF
|
287.98 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
